Esophagus HU
Esophagus HU
Esophagus HU
Surgical anatomy
• Esophagus is a narrow muscular tube extending from pharynx to the stomach.
• descends in front of the vertebral column goes through superior and posterior
mediastinum.
• It begins with lower part of the neck at the inferior border of the cricoid
cartilage(C6), extending to the cardiac orifice of the stomach(T11).
• It gives passage for chewed food (bolus) and liquids during the third stage of
deglutition.
PARTS OF THE ESOPHAGUS
The distance of each constriction is measured from the upper incisor teeth.
First constriction (cervical) at the pharyngo- esophageal junction (at C6) 9 cm (6 inches) from
the incisor teeth.
Second constriction (thoracic) where it’s crossed by the arch of aorta (at T4) 22.5 cm (9 inches)
from the incisor teeth.
Third constriction (thoracic) where it’s crossed by the left principal bronchus(at T5-T6) 27.5 cm
(11 inches) from the incisor teeth
Fourth constriction (diaphragmatic) where it pierces the diaphragm (at T10) 40 cm (15 inches)
from the incisor teeth.
These constrictions are important as they are the likely sites of obstruction in the event of
oesophageal scarring due to the swallowing of caustic or acidic material.
CLINICAL IMPORTANCE OF ESOPHAGEAL CONSTRICTIONS
•Pulmonary complications •
◦ Asthma •
◦ Chronic dry cough • .
◦ Aspiration Pneumonia •
◦ Bronchiectasis •
◦ Pulmonary Fibrosis
• Miscellaneous •
◦ Dyspepsia (nausea, vomiting, abdominal Pain) •
◦ Anorexia, Wt. Loss •
◦ Anemia, Fatigue •
◦ Hiccups •
◦ Burning Mouth •
◦ Sleep disturbances
• E.N.T Complications •
◦ Sore Throat •
◦ Hoarseness/Laryngitis •
◦ Globus sensation •
◦ Throat Clearing •
◦ Chronic Otitis media and Sinusitis •
◦ Dental erosions •
◦ Laryngeal cancer
Evaluation
Endoscopy :Exclude other diseases esp. tumour . Document presence of peptic esophageal
injury and To assess the degree of injury and Biopsy
Manometry : To rule out primary motility disorders
pH monitoring :24 hr pH test- gold standard for diagnosing and quantifying acid
reflux .Assess : 1-total number of reflux episodes ( pH <4) 2- Number of episodes >5 min 3-
Extent of reflux in upright position 4-Extent of reflux in supine position
Esophagography :True value of the study is to determine the external anatomy of esophagus
and stomach ** To rule out peptic esophageal strictures, diverticula, tumors, hernias
Imaging??
Treatment
Medical:
Medical and Lifestyle modifications :
◦ Weight loss
◦ Head end elevation of bedAvoidance of meal 2-3 hrs before bed time
◦ Avoidance of chocolate, caffeine, alcohol, spicy/acidic foods
◦ 8 week course of PPI ‘s
Endoscopic :
◦ Plicating gastric mucosa just below cardia to accentuate Angle of His
◦ Radiofrequency ablation of sphincter
◦ Injection of submucosal polymers to lower esophagus
Barrett’s oesophagus (columnarlined
lower oesophagus)
Barrett's oesophagus, sometimes called Barrett syndrome or Columnar epithelium lined lower
oesophagus (CELLO).
Barrett esophagus is a complication of chronic GERD ( 5-15%) that is characterized by intestinal
metaplasia within the esophageal squamous mucosa.
• Barrett esophagus is defined as the replacement of the normal distal stratified squamous
mucosa by metaplastic columnar epithelium containing goblet cells.
Epidemiology
• The incidence of Barrett esophagus is rising, and it is estimated to occur in as many as 10% of
individuals with symptomatic GERD.
• Barrett esophagus is most common in white (Caucasian) males and it typically presents
between 40 and 60 years of age.
• The greatest concern in Barrett esophagus is that it confers an increased risk of esophageal
adenocarcinoma. *30-40
Barrett’s oesophagus
A pre-malignant condition Molecular studies suggest that Barrett epithelium may be more
similar to adenocarcinoma than to normal esophageal epithelium, consistent with the view
that Barrett esophagus is a pre- malignant condition.
Epithelial dysplasia Epithelial dysplasia, considered to be a pre-invasive lesion, is detected in
0.2% to 2.0% of persons with Barrett esophagus each year and is associated with prolonged
symptoms and increased patient age
Although the vast majority of esophageal adenocarcinomas are associated with Barrett
esophagus, it is important to remember that most (90%) individuals with Barrett esophagus do
not develop esophageal tumors.
Diagnosis•
◦ Diagnosis of Barrett esophagus requires both endoscopic evidence of abnormal mucosa
above the gastroesophageal junction and histologically documented intestinal metaplasia.
Clinical Features.
◦ • Barrett esophagus can only be identified thorough endoscopy and biopsy, which are
usually prompted by GERD symptoms (dysphagia, heartburn, regurgitation of sour-tasting
gastric contents & attacks of severe chest pain)
Treatment
Surgical resection, or esophagectomy, Photodynamic therapy, Laser ablation, and
Endoscopic mucosectomy.
MOTILITY DISORDERS AND
DIVERTICULA
Introduction
◦ Disruption of coordinated, sequential motility pattern limiting motion of delivery of food and fluid
◦ Common symptoms dysphagia and chest pain •
◦ Not very common •
◦ May be part of a more diffuse gastrointestinal motility problem •
◦ May be associated with GERD
Achalasia
Botulinum toxin •
◦ Acts by interfering with cholinergic excitatory neuronal activities at LES •
◦ Not permanent and has to be injected every few months endoscopically •
◦ For elderly patient if surgery contraindicated
Pneumatic dilatation •
• Involves stretching the cardia with a balloon to disrupt the muscle and render it less
competent •
• Perforation is the major complication •
• The risk of perforation increases with bigger balloons •
• should be used cautiously for progressive dilatation over a period of weeks •
• Forceful dilatation is curative in 75–85% of cases •
• The results are best in patients aged more than 45 years
Heller’s myotomy •
• This involves cutting the muscle of the lower esophagus and cardia •
• The major complication is gastro-esophageal reflux •
• most surgeons therefore add a partial anterior fundoplication (Heller–Dor’s operation)
• It is successful in more than 90% of cases and may be used after failed dilatation
Zenker’s diverticulum (pharyngeal
pouch)
Posterior protrusion of esophageal wall above cricopharyngeal sphincter through the natural
weak point (the dehiscence of Killian) between the oblique and horizontal (cricopharyngeus)
fibres of the inferior pharyngeal constrictor
exact mechanism to its formation is unknown, but it involves loss of the coordination between
pharyngeal contraction and opening of the upper sphincter
As the pouch enlarges, it tends to fill with food on eating, and the fundus descends into the
mediastinum
This leads to halitosis and esophageal dysphagia •
Coughing out of same food several hours after ingestion
Treatment
• Endoscopically with a linear cutting stapler to divide septum between the diverticulum and
the upper esophagus, producing a diverticulo-esophagostomy,
or
.Open surgery involving pouch excision, pouch suspension (diverticulopexy) and/or myotomy
of the cricopharyngeus •
All techniques have good results
Disorders of body of esophagus
Diffuse Esophageal Spasm: •
f>m
Motor abnormality of lower 2/3rd of esophagus •
Muscular hypertrophy and degeneration of vagus branches •
Repetitive simultaneous and high amplitude esophageal contractions •
C/f: Chest pain (mimics angina), dysphagia • Aggravated by acid reflux, dinking cold liquids,
heightened emotional stress •
10% LES relaxation on wet swallow
Diffuse Esophageal Spasm:
Diagnosis:
◦ Radiograph- Corkscrew esophagus or pseudo- diverticulosis on esophagogram, distal bird beak sign
or normal peristalsis can also be present
◦ Manometry- Simultaneous multipeaked contractions and intermittent normal peristalsis of high
amplitude (>120mmHg) or long duration (>2.5 secs)
Diffuse Esophageal Spasm
Treatment: •
◦ Psychiatric evaluation is done along with elimination of trigger factor •
◦ Acid suppression, nitrates, calcium channel blockers, sedatives or
anticholinergics is used •
◦ Bougie dilatation of esophagus (50-60 fr) •
◦ Botulinum toxin injection
◦ Surgery:
◦ Indication- severe chestpain, dysphagia or pulsion diverticula of thoracic esophagus Procedure-
long Esophagomyotomy through left thoracotomy or video assisted technique (proximally, from
thoracic inlet to distal extent to LES)
Nutcracker Esophagus (hypercontractile esophagus):
treatment :
• asymptomatic tumors with typical EUS features: expectant therapy and EUS observation •
Symptomatic : removal :ENUCULATION
• DDx • Leiomyosarcoma • GISTs :(originate from GI pacemaker cells of Cajal, stain positively for
tyrosine kinase and should be excised by esophagectomy.
Esophageal lio-myoma
OTHER NON-NEOPLASTIC
CONDITIONS
Schatzki’s ring
Schatzki’s ring is a circular ring in the distal oesophagus , usually at the squamocolumnar
junction.
cause is obscure, but there is a strong association with reflux disease.
The core of the ring consists of variable amounts of fibrous tissue and cellular infiltrate.
Most rings are incidental findings.
Some are associated with dysphagia and respond to dilatation in conjunction with medical
antireflux therapy.
Chagas’ disease
This condition is confined to South American countries, but is of interest because oesophageal
symptoms occur that are similar to severe achalasia.
It is caused by a protozoan, Trypanosoma cruzi, transmitted by an insect vector.
Parasites reach the bloodstream and, after a long latent period, there is damage particularly to
cardiac and smooth muscle.
Destruction of both Auerbach’s and Meissner’s plexus leads to acquired megaoesophagus.
Plummer–Vinson syndrome
This is also called the Paterson–Kelly (or Paterson–Brown Kelly) syndrome or sideropenic dysphagia
Dysphagia is said to occur because of the presence of a postcricoid web that is associated with iron
deficiency anaemia, glossitis and koilonychia.
The classic syndrome is rarely complete.
Some patients may have oropharyngeal leukoplakia, and this may account for an alleged increased risk
of developing hypopharyngeal cancer.
Webs certainly occur in the upper and middle oesophagus, usually without any kind of associated
syndrome.
They are nearly always thin diaphanous membranes identified coincidentally by contrast radiology.
Even symptomatic webs that cause a degree of obstruction may be inadvertently ruptured at endoscopy.
Few require formal endoscopic dilatation
Cancer of the Esophagus
Ca esophagus is the 6th most common cancer in the world.
Worldwide, squamous cell cancer is most common, but adenocarcinoma predominates in the
west and is increasing in incidence
Esophageal cancer most commonly presents in the sixth to seventh decades of life.
It is a male predominant disease with M:F ratio of 3:1 for Sq. ca and 15:1 for Adeno Ca.
Types of Ca Esophagus:
Although a CT scan is helpful, its accuracy is only 57% for T staging, 74% for N staging, and
83% for M staging.
Diagnosis
PET: An 18 F-fluorodeoxyglucose (FDG)– positron emission tomography (PET) scan evaluates
the primary mass, regional lymph nodes, and distant disease.
MRI
. It can accurately detect T4 lesions and metastatic lesions in the liver but overstages T and N
status, with only a 74% accuracY
Diagnosis
Endoscopic ultrasound:
EUS is the most critical component of esophageal cancer staging
The information obtained from EUS will help guide medical and surgical therapy
The experienced endoscopic ultrasonographer can identify
◦ the depth and length of the tumor,
◦ degree of luminal compromise,
◦ status of regional lymph nodes,
◦ involvement of adjacent structures.
◦ biopsy samples can be obtained of the mass and lymph nodes in the paratracheal, subcarinal,
paraesophageal, celiac, lesser curvature, and gastrohepatic regions.
Diagnosis
Bronchoscopy, mediastinoscopy, thoracoscopy, and laparoscopy are all useful staging tools
Tis High-grade dysplasia
T1 Tumour invading lamina propria or submucosa
T2 Tumour invading muscularis propria
T3 Tumour invading beyond muscularis propria
T4a Tumour invading adjacent structures (pleura, pericardium,
diaphragm)
T4b Tumour invading adjacent structures (trachea, bone, aorta)
N0 No lymph node metastases
N1 Lymph node metastases in 1–2 nodes
N2 Lymph nodes metastases in 3–6 nodes
N3 Lymph node metastases in 7 or more lymph nodes
M0 No distant metastases
M1 All other distant metastases
Stage 1A: T1N0M0; 1B: T2N0M0; 2A: T3N0M0; 2B: T1/2N0M0;
3A: T4aN0M0, T3N1M0, T1/2N2M0
Stage 3B: T3N2M0; 3C: T4aN1/2M0, T4bN0–3M0, T1–4N3M0;
4T:1–4N1–3M
Treatment of malignant tumours
PRINCIPLES:
At the time of diagnosis, around two-thirds of all patients with oesophageal cancer will already
have incurable disease.
The aim of palliative treatment is to overcome debilitating or distressing symptoms while
maintaining the best quality of life possible for the patient.
As dysphagia is the predominant symptom in advanced oesophageal cancer, the principal aim of
palliation is to restore adequate swallowing.
A variety of methods is available and, given the short life expectancy of most patients, it is
important that the choice of treatment should be tailored to each individual.
Once oesophageal neoplasms reach the submucosal layer of the oesophagus, the tumour has
access to the lymphatic system, meaning that, even at this early local stage, there is an incidence
of nodal positivity for both squamous cell carcinoma and adenocarcinomas of about 20%.
.Radical oesophagectomy is the most important aspect of curative treatment
Neoadjuvant treatments before surgery may improve survival in a proportion of patients
Chemoradiotherapy alone may cure selected patients, particularly those with squamous cell
cancers
Useful palliation may be achieved by chemo-/radiotherapy or endoscopic treatment
Treatments with curative intent
SURGERY
Histological tumour type, location and the extent of the proposed lymphadenectomy.
TWO-PHASE OESOPHAGECTOMY (ABDOMEN AND RIGHT CHEST, IVOR LEWIS)
TRANSHIATAL OESOPHAGECTOMY (WITHOUT THORACOTOMY).
NEOADJUVANT TREATMENTS WITH SURGERY .
Postoesophagectomy
● Reflux may be a problem after resection
● Symptoms may be atypical
● Reflux may be limited or avoided by subtotal oesophagectomy and gastric transposition high in the
chest
Non-surgical treatments
Radiotherapy alone.
Chemoradiotherapy. : may be a useful alternative to surgery, especially in unfit patients .
Palliative treatment:
Surgical resection and external beam radiotherapy may be used for palliation, but are not suitable
when the expected survival is short, because most of the remainder of life will be spent recovering
from the ‘treatment’.
Intubation: metallic stent
Endoscopic laser treatment may be used to core a channel through the tumour. It is based on
thermal tumour destruction.
Brachytherapy is a method of delivering intraluminal radiation with a short penetration distance
(hence the prefix ‘brachy’) to a tumour.
Malignant tracheo-oesophageal fistula.
Some have advocated surgical bypass and oesophageal exclusion, but this is a major procedure.
An expanding metal stent is probably the best treatment.